L. J. Brandes - Concepedia

Author

L. J. Brandes

University of Manitoba

Also Known As

L BRANDES, L Brandes, L J Brandes, L M Brandes, L. Brandes, L. J. Brandes, L.J. BRANDES, L.J. Brandes, Lauren Brandes

Publications

743

Citations

H-Index

Concepts

All Affiliations

University of Manitoba University of Saskatchewan

About

L. J. Brandes is an author at University of Manitoba specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	370
2	Biochemistry	5	5	136
3	Natural Sciences	4	4	113
4	Health Sciences	1	1	10
5	Allergy	1	1	13

L. J. Brandes

Publications

671

Citations

H-Index

Page 1

	Year	Citations
Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses. L. J. Brandes, R. J. Arron, R.Patricia Bogdanovic, PubMed Malignant GrowthPsychotropic MedicationPsychopharmacologyPharmacotherapyTumor Biology	1992	211
Increased Therapeutic Index of Antineoplastic Drugs in Combination With Intracellular Histamine Antagonists L. J. Brandes, Frank S. LaBella, R. C. Warrington JNCI Journal of the National Cancer Institute	1991	59
H<sub>3</sub> receptor antagonist, thioperamide, inhibits adrenal steroidogenesis and histamine binding to adrenocortical microsomes and binds to cytochrome P450 Frank S. LaBella, Gary Queen, Gary B. Glavin, British Journal of Pharmacology	1992	57
Histamine and growth: interaction of antiestrogen binding site ligands with a novel histamine site that may be associated with calcium channels. L. J. Brandes, R.Patricia Bogdanovic, Max D. Cawker, PubMed Novel Histamine SiteCalcium ChannelsPharmacotherapyMolecular PharmacologyMedicinal Chemistry	1987	55
Enhanced Cancer Growth in Mice Administered Daily Human-Equivalent Doses of Some H1-Antihistamines: Predictive In Vitro Correlates L. J. Brandes, R. C. Warrington, R. J. Arron, JNCI Journal of the National Cancer Institute	1994	52
Results of a clinical trial in humans with refractory cancer of the intracellular histamine antagonist, N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine-HCl, in combination with various single antineoplastic agents. L. J. Brandes, Kai Simons, S P Bracken, Journal of Clinical Oncology	1994	39
Correlation of the antiproliferative action of diphenylmethane-derivative antiestrogen binding site ligands with antagonism of histamine binding but not of protein kinase C-mediated phosphorylation. L. J. Brandes, Jon M. Gerrard, R P Bogdanovic, PubMed Chemoprevention StrategyCellular PharmacologyChemical BiologyPlatelet AggregationMolecular Pharmacology	1988	36
N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine in combination with cyclophosphamide: an active, low-toxicity regimen for metastatic hormonally unresponsive prostate cancer. L. J. Brandes, S P Bracken, Ernest W. Ramsey Journal of Clinical Oncology	1995	35
PHASE II TRIAL OF TESMILIFENE PLUS MITOXANTRONE AND PREDNISONE FOR HORMONE REFRACTORY PROSTATE CANCER: HIGH SUBJECTIVE AND OBJECTIVE RESPONSE IN PATIENTS WITH SYMPTOMATIC METASTASES Derek Raghavan, L. J. Brandes, Kathi Klapp, The Journal of Urology	2005	27
The Antiproliferative Potency of Histamine Antagonists Correlates with Inhibition of Binding of [3H]-Histamine to Novel Intracellular Receptors (HIC) in Microsomal and Nuclear Fractions of Rat Liver L. J. Brandes, James Davie, F. Paraskevas, Birkhäuser Basel eBooks HepatologyBiochemistrySpecific Hic AntagonistLiver PhysiologyPotent Aebs Ligand	1991	23

Page 1